{"product_id":"s-4mg-auto-injector-pen","title":"S4mg Auto-Injector Pen or Vial","description":"\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" role=\"tabpanel\" id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content wc-tab\"\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003ePlease note:\u003c\/b\u003e This item is shipped directly from the manufacturer. Delivery may take slightly longer than usual, with an estimated turnaround time of 5 to 7 working days.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eNovo-Lela S4mg Auto-Injector Pen contains a GLP-1 receptor agonist approved for the treatment of type 2 diabetes. S4mg replicates the action of human glucagon-like peptide-1, enhancing glucose-dependent insulin secretion and suppressing glucagon release to regulate blood sugar levels effectively.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eAs a next-generation incretin therapy, S4mg has shown significant efficacy in reducing HbA1c levels and promoting weight loss. Clinical studies consistently demonstrate that S4mg provides superior glycaemic control compared to placebo and many other GLP-1 receptor agonists. Its additional effects on delaying gastric emptying further improve postprandial glucose control and contribute to reduced appetite and caloric intake.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eThe Auto-Injector Pen format offers a convenient, prefilled option for once-weekly subcutaneous administration, making treatment simple and discreet.\u003c\/p\u003e\n\u003cdiv class=\"MsoNormal\" align=\"center\" style=\"text-align: center;\"\u003e\u003chr size=\"2\" width=\"100%\" align=\"center\"\u003e\u003c\/div\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003eBenefits of S4mg:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul style=\"margin-top: 0cm;\" type=\"disc\"\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eBlood Sugar Regulation:\u003c\/b\u003e Stimulates insulin secretion in response to high glucose and suppresses glucagon production, supporting stable blood sugar control.\u003c\/li\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eWeight Loss Support:\u003c\/b\u003e Reduces appetite and slows gastric emptying, assisting with sustained weight reduction.\u003c\/li\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eCardiovascular Protection:\u003c\/b\u003e Evidence suggests a reduction in the risk of major adverse cardiovascular events in patients with type 2 diabetes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"MsoNormal\" align=\"center\" style=\"text-align: center;\"\u003e\u003chr size=\"2\" width=\"100%\" align=\"center\"\u003e\u003c\/div\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003eDosage Instructions:\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eNovo-Lela S4mg Auto-Injector Pen is designed for \u003cb\u003esubcutaneous injection\u003c\/b\u003e, providing a pre-measured dose.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003eGeneral guidelines are as follows:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul style=\"margin-top: 0cm;\" type=\"disc\"\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l0 level1 lfo2; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eType 2 Diabetes:\u003c\/b\u003e Start with 0.25 mg once weekly for the first four weeks, then increase to 0.5 mg once weekly. The dose may be escalated to 1.0 mg if additional glycaemic control is needed.\u003c\/li\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l0 level1 lfo2; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eWeight Management:\u003c\/b\u003e Higher maintenance doses (up to 2.4 mg weekly) may be used based on clinical judgment and patient response.\u003c\/li\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l0 level1 lfo2; tab-stops: list 36.0pt;\"\u003eAdminister the injection on the same day each week, at any time, with or without food.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"MsoNormal\"\u003eAlways follow your healthcare provider’s instructions to ensure the correct dose and frequency are used.\u003c\/p\u003e\n\u003cdiv class=\"MsoNormal\" align=\"center\" style=\"text-align: center;\"\u003e\u003chr size=\"2\" width=\"100%\" align=\"center\"\u003e\u003c\/div\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003eSide Effects:\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eS4mg may cause certain side effects, although many are mild and improve with time:\u003c\/p\u003e\n\u003cul style=\"margin-top: 0cm;\" type=\"disc\"\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eGastrointestinal Symptoms:\u003c\/b\u003e Nausea, vomiting, diarrhea, or abdominal discomfort during dose escalation.\u003c\/li\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eHypoglycemia:\u003c\/b\u003e Uncommon when used alone but can occur if combined with other blood sugar-lowering medications.\u003c\/li\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eInjection Site Reactions:\u003c\/b\u003e Mild redness, itching, or discomfort may occur.\u003c\/li\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003ePancreatitis:\u003c\/b\u003e Rare cases of pancreatic inflammation have been reported.\u003c\/li\u003e\n\u003cli class=\"MsoNormal\" style=\"mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"\u003e\n\u003cb\u003eGallbladder Effects:\u003c\/b\u003e Long-term use may increase the risk of gallbladder-related events.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"MsoNormal\"\u003ePatients should consult their healthcare provider regarding monitoring and management of potential side effects.\u003c\/p\u003e\n\u003cdiv class=\"MsoNormal\" align=\"center\" style=\"text-align: center;\"\u003e\u003chr size=\"2\" width=\"100%\" align=\"center\"\u003e\u003c\/div\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003eHalf-life:\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eS4mg has a \u003cb\u003ehalf-life of about one week\u003c\/b\u003e, allowing for \u003cb\u003eonce-weekly injections\u003c\/b\u003e. This extended activity ensures consistent glucose control and facilitates weight management without daily dosing.\u003c\/p\u003e\n\u003cdiv class=\"MsoNormal\" align=\"center\" style=\"text-align: center;\"\u003e\u003chr size=\"2\" width=\"100%\" align=\"center\"\u003e\u003c\/div\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003eIn summary\u003c\/b\u003e, Novo-Lela S4mg Auto-Injector Pen offers the same therapeutic benefits as traditional delivery methods, with the added convenience of a prefilled pen. It is a clinically effective GLP-1 receptor agonist that supports blood sugar control, weight loss, and cardiovascular health as part of a comprehensive treatment plan.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Ampoule","offer_id":52072903409962,"sku":null,"price":2250.0,"currency_code":"ZAR","in_stock":true},{"title":"Pen","offer_id":52072903442730,"sku":null,"price":2250.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0974\/2132\/8682\/files\/S4mgv2.png?v=1784011086","url":"https:\/\/myantidote.co.za\/products\/s-4mg-auto-injector-pen","provider":"My Antidote","version":"1.0","type":"link"}